Suchergebnisse - "Addolorato, Giovanni"

PubPharm (374)

1

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021 : a systematic analysis for the Global Burden of Disease Study 2021

enthalten in: Lancet (London, England) | 2024

von GBD 2021 Diseases and Injuries Collaborators | Ferrari, A. | Santomauro, D. | +98

2

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021 : a systematic analysis for the Global Burden of Disease Study 2021

enthalten in: Lancet (London, England) | 2024

von GBD 2021 Causes of Death Collaborators | Naghavi, M. | Ong, K. | +98

ErratumIn: Lancet. 2024 Apr 19;:. - PMID 38648809

3

Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment

enthalten in: European journal of internal medicine | 2024

von Addolorato, G. | Alho, H. | Bresciani M De Andrade, P. | +3

4

Prothrombin time predicts steroid response in severe alcohol-related hepatitis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Tarli, C. | Mannucci, S. | Vecchione, M. | +11

5

Education and Training in Alcohology in Italy

enthalten in: European addiction research | 2024

von Agabio, R. | Domenicali, M. | Zavan, V. | +1

6

Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease

enthalten in: Nutrients | 2024

von Andaloro, S. | Mancuso, F. | Miele, L. | +3

7

AUD in perspective

enthalten in: International review of neurobiology | 2024

von de Bejczy, A. | Addolorato, G. | Aubin, H. | +5

8

Current treatments of alcohol use disorder

enthalten in: International review of neurobiology | 2024

von Dionisi, T. | Di Sario, G. | De Mori, L. | +10

9

Prothrombin time predicts steroid response in severe alcohol‐related hepatitis

enthalten in: Liver International | 2024

von Tarli, C. | Mannucci, S. | Vecchione, M. | +11

10

A Prospective Pharmacogenetic Phase 3 Clinical Trial of Low-Dose Ondansetron (A 5-HT3 Antagonist) to Treat Heavy and Very Heavy Drinkers With Alcohol Use Disorder

enthalten in: ResearchSquare.com | 2023

von Johnson, B. | Alho, H. | Addolorato, G. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[38]